The EVLTAP group had lower VCSS scores at 12weeks ( median 0 ( i.q.r. 0-1 ) versus 2 ( 0-2 ) ; P < 0001 ) , and lower AVVQ scores at 6weeks ( median 79 ( i.q.r. 41-107 ) versus 135 ( 109-181 ) ; P < 0001 ) and 12weeks ( 20 ( 04-77 ) versus 96 ( 22-138 ) ; P = 0015 ) .